Logo image of BMEZ

BLACKROCK HLTH SCI TRM TR II (BMEZ) Stock Price, Quote, News and Overview

NYSE:BMEZ - New York Stock Exchange, Inc. - US09260E1055 - Currency: USD

14.15  +0.07 (+0.5%)

After market: 14.08 -0.07 (-0.49%)

Fundamental Rating

3

Taking everything into account, BMEZ scores 3 out of 10 in our fundamental rating. BMEZ was compared to 0 industry peers in the Unkown industry. While BMEZ seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, BMEZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BMEZ was profitable.
In the past year BMEZ had a positive cash flow from operations.
BMEZ Yearly Net Income VS EBIT VS OCF VS FCFBMEZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 1B -1B -2B

1.2 Ratios

Industry RankSector Rank
ROA 9.02%
ROE 9.45%
ROIC N/A
ROA(3y)-12.9%
ROA(5y)N/A
ROE(3y)-13.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMEZ Yearly ROA, ROE, ROICBMEZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 -20

1.3 Margins

BMEZ's Profit Margin has declined in the last couple of years.
BMEZ does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 1956.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-69.58%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMEZ Yearly Profit, Operating, Gross MarginsBMEZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5K -5K 10K 15K

5

2. Health

2.1 Basic Checks

BMEZ has less shares outstanding than it did 1 year ago.
BMEZ has a worse debt/assets ratio than last year.
BMEZ Yearly Shares OutstandingBMEZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
BMEZ Yearly Total Debt VS Total AssetsBMEZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 8.83 indicates that BMEZ is not in any danger for bankruptcy at the moment.
BMEZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.83
ROIC/WACCN/A
WACCN/A
BMEZ Yearly LT Debt VS Equity VS FCFBMEZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 1B -1B 2B -2B 3B

2.3 Liquidity

A Current Ratio of 0.48 indicates that BMEZ may have some problems paying its short term obligations.
A Quick Ratio of 0.48 indicates that BMEZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
BMEZ Yearly Current Assets VS Current LiabilitesBMEZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

4

3. Growth

3.1 Past

BMEZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.39%, which is quite impressive.
The earnings per share for BMEZ have been decreasing by -61.65% on average. This is quite bad
Looking at the last year, BMEZ shows a very strong growth in Revenue. The Revenue has grown by 43.05%.
Measured over the past years, BMEZ shows a very strong growth in Revenue. The Revenue has been growing by 23.73% on average per year.
EPS 1Y (TTM)110.39%
EPS 3Y-61.65%
EPS 5YN/A
EPS Q2Q%-174.49%
Revenue 1Y (TTM)43.05%
Revenue growth 3Y23.73%
Revenue growth 5YN/A
Sales Q2Q%58.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMEZ Yearly Revenue VS EstimatesBMEZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2M 4M 6M 8M 10M

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.46 indicates a rather expensive valuation of BMEZ.
Compared to an average S&P500 Price/Earnings ratio of 28.87, BMEZ is valued a bit cheaper.
Industry RankSector Rank
PE 22.46
Fwd PE N/A
BMEZ Price Earnings VS Forward Price EarningsBMEZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.62
EV/EBITDA N/A
BMEZ Per share dataBMEZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.82%, BMEZ is a good candidate for dividend investing.
BMEZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 13.82%

5.2 History

BMEZ has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BMEZ Yearly Dividends per shareBMEZ Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BMEZ pays out 98.89% of its income as dividend. This is not a sustainable payout ratio.
DP98.89%
EPS Next 2YN/A
EPS Next 3YN/A
BMEZ Yearly Income VS Free CF VS DividendBMEZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 1B -1B -2B
BMEZ Dividend Payout.BMEZ Dividend Payout, showing the Payout Ratio.BMEZ Dividend Payout.PayoutRetained Earnings

BLACKROCK HLTH SCI TRM TR II

NYSE:BMEZ (4/28/2025, 8:04:00 PM)

After market: 14.08 -0.07 (-0.49%)

14.15

+0.07 (+0.5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners41.7%
Inst Owner Change0.28%
Ins Owners0.02%
Ins Owner Change0%
Market Cap1.43B
Analysts0
Price TargetN/A
Short Float %0.36%
Short Ratio1
Dividend
Industry RankSector Rank
Dividend Yield 13.82%
Yearly Dividend1.61
Dividend Growth(5Y)N/A
DP98.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date04-15 2025-04-15 (0.17397)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 22.46
Fwd PE N/A
P/S 144.15
P/FCF 5.62
P/OCF 5.62
P/B 0.7
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)0.63
EY4.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.52
FCFY17.79%
OCF(TTM)2.52
OCFY17.79%
SpS0.1
BVpS20.33
TBVpS20.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.02%
ROE 9.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1956.24%
GM N/A
FCFM 2564.39%
ROA(3y)-12.9%
ROA(5y)N/A
ROE(3y)-13.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-69.58%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 131.09%
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 8.83
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.39%
EPS 3Y-61.65%
EPS 5YN/A
EPS Q2Q%-174.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.05%
Revenue growth 3Y23.73%
Revenue growth 5YN/A
Sales Q2Q%58.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.67%
OCF growth 3YN/A
OCF growth 5YN/A